Zobrazeno 1 - 7
of 7
pro vyhledávání: '"JoAnn Proper"'
Autor:
Janine Morrissey, Bruce J. Dezube, James D. Dixon, William Weeden, Christopher O’Loughlin, Lisa A. Williams, Vern J. Choy, Jielin Zhang, Eve M. Burns, JoAnn Proper, Clyde S. Crumpacker, Frank B. Gelder, Paul J. Pickering
Publikováno v:
The Journal of Infectious Diseases. 187:500-503
(PE)HRG214 (HRG) is a polyclonal antibody preparation produced by immunization of goats with purified human immunodeficiency virus (HIV) antigens. In this phase I study, HRG was administered intravenously as a single dose (1, 2, 4, 8, or 16 mg/kg) to
Autor:
Pamela Chatis, John P. Doweiko, Imad Nasser, JoAnn Proper, Katiri Wagner, Lori Panther, Will Weeden, Dana K. Fugelso, Bruce J. Dezube
Publikováno v:
Clinical Infectious Diseases. 38:1490-1492
We compared the pathological diagnoses obtained by anal Papanicolaou (Pap) smear with those obtained by anal biopsy or by surgical excision for 153 men who have sex with men (MSM). Analysis of these paired specimens showed that anal Pap smears were a
Autor:
Dana K. Fugelso, Lori Panther, Katiri Wagner, Ryan K. Murphy, JoAnn Proper, Bruce J. Dezube, Hans P. Schlecht, John P. Doweiko
Human papillomavirus causes anal condylomata, high-grade anal intraepithelial neoplasia, and anal squamous cell cancer. We found high-grade intraepithelial neoplasia or squamous cell cancer in 75 (47%) of 159 HIV-seropositive men who have sex with me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a08fadb785c938b684bc0715bd34fa
https://europepmc.org/articles/PMC4460603/
https://europepmc.org/articles/PMC4460603/
Autor:
Jeffrey G. Supko, Jeffrey W. Clark, Moira Kirvan, Susan L. Connors, Thomas A. Puchalski, Barbara Rattner, Joann Proper, Rocio Garcia-Carbonero, C. Sidor, Joseph Paul Eder, Lowell E. Schnipper, Milos J. Janicek, William E. Fogler, David P. Ryan, Judah Folkman, Eric N. Phillips, Mary T. Keogan, Donald Kufe, Lawrence N. Shulman, Nancy M. Kinchla
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(18)
PURPOSE: To perform a phase I trial of recombinant human endostatin (rhEndostatin; EntreMed, Rockville, MD) given as a daily 20-minute intravenous (IV) injection in adult patients with refractory solid tumors. PATIENTS AND METHODS: The daily dose was
Publikováno v:
Blood. 97(11)
Stromal cell-derived factor-1 (SDF-1), the ligand for the CXCR4 receptor, is a highly efficacious chemoattractant for CD34(+) hematopoietic progenitor cells. However, the SDF-1/CXCR4 signaling pathways that regulate hematopoiesis are still not well d
Autor:
Nancy Gillombardo, JoAnn Proper, Patty Forino, Kenneth B. Miller, James D. Levine, Paul G. Richardson, Therese Desliva, Donald Kufe, Jacalyn Rosenblatt, David Avigan, Robin Joyce, Zekui Wu, Baldev Vasir, Lynne Uhl, Kenneth C. Anderson, Marisa Villaroel, Nikhil C. Munshi
Publikováno v:
Blood. 104:751-751
Dendritic cell (DC)-tumor fusions effectively present a broad array of tumor associated antigens in the context of DC derived costimulation. Vaccination with fusion cells induces tumor specific immunity in animal models and clinical studies. We have
Autor:
Baldev Vasir, C. Macnamarra, Jacalyn Rosenblatt, Donald Kufe, Lynne Uhl, Kenneth B. Miller, Robin Joyce, James D. Levine, Nikhil C. Munshi, D. Donbagoda, Zekui Wu, Corrine Lenahan, David Avigan, A. Bisonette, P. Forino, JoAnn Proper
Publikováno v:
Biology of Blood and Marrow Transplantation. (2):26